Literature DB >> 25010533

The interplay between radiation and the immune system in the field of post-radical pneumonitis and fibrosis and why it is important to understand it.

Pelagia G Tsoutsou1.   

Abstract

A discussion on the importance and pathogenesis of radiation-induced pneumonitis and fibrosis is provided, with a special focus on the role of the immune system. The need to understand this interaction is highlighted in view of emerging therapeutic potential.

Entities:  

Keywords:  cytokines; immune system; radiation fibrosis; radiation pneumonitis

Mesh：

Year:  2014        PMID： 25010533     DOI： 10.1517/14656566.2014.938049

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


  7 in total

1.  Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.

Authors:  Shulian Wang; Jeff Campbell; Matthew H Stenmark; Jing Zhao; Paul Stanton; Martha M Matuszak; Randall K Ten Haken; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-03-14       Impact factor: 7.038

Review 2.  Effects of diabetes on the development of radiation pneumonitis.

Authors:  Guangtong Dong; Yuxiao Li; Qiyao Zhao; Bing Pang; Xin Qi; Junping Wei; Wei Hou
Journal:  Respir Res       Date:  2021-05-24

3.  Protective efficacy of inhaled quercetin for radiation pneumonitis.

Authors:  Meng Qin; Weijuan Chen; Juanjuan Cui; Wentao Li; Dongmei Liu; Weifen Zhang
Journal:  Exp Ther Med       Date:  2017-10-11       Impact factor: 2.447

4.  Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.

Authors:  Mohammed Alharbi; Stefan Janssen; Heiko Golpon; Michael Bremer; Christoph Henkenberens
Journal:  Radiat Oncol       Date:  2017-11-02       Impact factor: 3.481

5.  Investigating the SPECT Dose-Function Metrics Associated With Radiation-Induced Lung Toxicity Risk in Patients With Non-small Cell Lung Cancer Undergoing Radiation Therapy.

Authors:  Daniel R Owen; Yilun Sun; Philip S Boonstra; Matthew McFarlane; Benjamin L Viglianti; James M Balter; Issam El Naqa; Matthew J Schipper; Caitlin A Schonewolf; Randall K Ten Haken; Feng-Ming S Kong; Shruti Jolly; Martha M Matuszak
Journal:  Adv Radiat Oncol       Date:  2021-02-07

6.  Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.

Authors:  C Henkenberens; S Janssen; M Lavae-Mokhtari; K Leni; A Meyer; H Christiansen; M Bremer; N Dickgreber
Journal:  Radiat Oncol       Date:  2016-02-02       Impact factor: 3.481

7.  Irradiation enhanced risks of hospitalised pneumonopathy in lung cancer patients: a population-based surgical cohort study.

Authors:  Shih-Kai Hung; Yi-Chun Chen; Wen-Yen Chiou; Chun-Liang Lai; Moon-Sing Lee; Yuan-Chen Lo; Liang-Cheng Chen; Li-Wen Huang; Nai-Chuan Chien; Szu-Chi Li; Dai-Wei Liu; Feng-Chun Hsu; Shiang-Jiun Tsai; Michael Wy Chan; Hon-Yi Lin
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.